{
    "Trade/Device Name(s)": [
        "Bionexia\u2122 hCG Pregnancy Serum/Urine Cassette and Dipstick Tests",
        "Bionexia\u2122M hCG Pregnancy Serum/Urine Cassette and Dipstick Tests",
        "ADT's Bionexia\u2122 hCG Pregnancy Serum/Urine Cassette and Dipstick Tests"
    ],
    "Submitter Information": "Applied DNA Technologies Inc.",
    "510(k) Number": "K071030",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHI"
    ],
    "Summary Letter Date": "June 29, 2007",
    "Summary Letter Received Date": "April 11, 2007",
    "Submission Date": "March 25, 2007",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Visual qualitative detection"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Cassette",
        "Dipstick"
    ],
    "Document Summary": "FDA 510(k) summary for Bionexia hCG Pregnancy Serum/Urine Cassette and Dipstick Tests for visual, qualitative detection of hCG to aid in early determination of pregnancy.",
    "Indications for Use Summary": "Rapid chromatographic immunoassays for visual, qualitative detection of hCG in serum or urine specimens at 20 mIU/mL and above to aid in early determination of pregnancy; for healthcare professional use.",
    "fda_folder": "Clinical Chemistry"
}